Majorly frustrating23 Nov 2021 13:28
The amount of times I’ve topped up & checked these boards (and stocktwits/ADVFN etc) for updates is soul destroying. There is a group on telegram but you can’t say anything remotely factual without being accused of de-ramping.
I Have been a defender of the team with Tils/Accustem debacle but it just beggars belief now
WHAT IS HAPPENING.
HOW HAVE THEY F****D UP THE CHANGE TO NASDAQ ONLY LISTING.
WHAT WAS THE POINT OF THE AIM TO MAIN MARKET LSE LISTING PREVIOUSLY?
WHAT IN THE F IS HAPPENING WITH ACCUSTEM
WHERE HAVE THE COVID TRIALS GONE
WHAT WAS THE PRECISION DEAL WORTH
WHY THE CHANGE TO BERMUDA
I’ve said it before and I’ll say it again, this either reeks of a buyout/JV or big news or it’s just pathetic shoddy lifestyle leadership. I’m sick of discussing the CV’s of employees here and how they are working on the next best thing, it’s currently burning cash with NO UPDATES. I’m sure some of them have had illustrious careers and are phenomenal in their field but the real important thing is the BOD & specifically GC & KS.
Why no god damn updates?
Are they waiting for the 40 day quiet period to end?
I don’t expect things overnight but if I have to look at one more investor call conference I am going to launch my phone out of the window!
KS, “Now, foralumab is the only fully human anti cd3 blah blah blah”
I knew I should have sold as soon as those covid results came, I have held on and held on and the team have seemingly made no progress in a year.
I apologise to them if they are reading this and unable to discuss things, but come on, we have all waited long enough now.